StockData
Bioceres Crop Solutions Corp. logo

Bioceres Crop Solutions Corp. (BIOX) stock

BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 1/30
$0.22−0.01 (-4.60%)

Close on Nov 12, 2026Market cap $14.17MP/E –Yield –

Bioceres Crop Solutions r&d expenses

Research and development expenses are spending on new products and technology.

Bioceres Crop Solutions's R&D Expenses for the twelve months ending Dec 31, 2025 was $14.37M, down 6.3% year over year. For fiscal 2026 it was $11.03M, up 16.7% from the year before. The highest annual figure on record is $15.35M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026$11.03M+16.7%
FY2025Jun 30, 2025$9.46M+12.9%
FY2024Jun 30, 2024$8.37M-45.4%
FY2023Jun 30, 2023$15.35M+120.9%
FY2022Jun 30, 2022$6.95M+23.7%
FY2021Jun 30, 2021$5.62M+33.9%
FY2020Jun 30, 2020$4.20M+13.7%
FY2019Jun 30, 2019$3.69M+332.1%
FY2016Dec 31, 2016$853.85K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025$2.35M+19.3%
Q1 FY2026CQ3 2025Sep 30, 2025$5.72M+29.6%
Q4 FY2025CQ2 2025Jun 30, 2025$2.65M-50.6%
Q3 FY2025CQ1 2025Mar 31, 2025$3.66M+1.9%
Q2 FY2025CQ4 2024Dec 31, 2024$1.97M-46.0%
Q1 FY2025CQ3 2024Sep 30, 2024$4.41M-3.7%
Q4 FY2024CQ2 2024Jun 30, 2024$5.37M+29.6%
Q3 FY2024CQ1 2024Mar 31, 2024$3.59M-7.8%
Q2 FY2024CQ4 2023Dec 31, 2023$3.64M+5.4%
Q1 FY2024CQ3 2023Sep 30, 2023$4.58M+18.9%
Q4 FY2023CQ2 2023Jun 30, 2023$4.14M+80.4%
Q3 FY2023CQ1 2023Mar 31, 2023$3.89M+112.1%
Q2 FY2023CQ4 2022Dec 31, 2022$3.46M+149.8%
Q1 FY2023CQ3 2022Sep 30, 2022$3.85M+245.5%
Q4 FY2022CQ2 2022Jun 30, 2022$2.30M+148.6%
Q3 FY2022CQ1 2022Mar 31, 2022$1.84M+3920.6%
Q2 FY2022CQ4 2021Dec 31, 2021$1.38M–
Q2 FY2021CQ4 2020Dec 31, 2020$1.11M–
Q2 FY2020CQ4 2019Dec 31, 2019$923.61K–
Q2 FY2019CQ4 2018Dec 31, 2018$45.67K–

More Bioceres Crop Solutions figures

See a number that looks wrong?